Judge Orders Drug Maker to Provide Experimental Treatment to Terminally Ill Teenager

New York Times - A 16-year-old patient, terminally ill with a rare form of muscular dystrophy, should be allowed to use an experimental drug treatment despite objections from the drug’s developer, a federal judge in Newark ruled on Wednesday.